Tsuyoshi Ando

607 total citations
17 papers, 481 citations indexed

About

Tsuyoshi Ando is a scholar working on Cellular and Molecular Neuroscience, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Tsuyoshi Ando has authored 17 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 5 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Tsuyoshi Ando's work include Neuroscience and Neuropharmacology Research (6 papers), Viral Infections and Vectors (5 papers) and Mosquito-borne diseases and control (4 papers). Tsuyoshi Ando is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Viral Infections and Vectors (5 papers) and Mosquito-borne diseases and control (4 papers). Tsuyoshi Ando collaborates with scholars based in Japan, Philippines and Myanmar. Tsuyoshi Ando's co-authors include Yoshihiro Watanabe, Kazuko Fujimoto, Takeshi Fujii, Koichiro Kawashima, Shin Yamada, Kazuo Sato, Satoshi Takeo, Norio Takagi, Kouichi Tanonaka and Takeshi Nabeshima and has published in prestigious journals such as Cancer Research, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Tsuyoshi Ando

17 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tsuyoshi Ando Japan 11 227 105 79 70 61 17 481
Malvika Gupta India 6 223 1.0× 129 1.2× 47 0.6× 44 0.6× 54 0.9× 6 446
Marzena J. Fabis United States 11 140 0.6× 93 0.9× 97 1.2× 23 0.3× 41 0.7× 11 638
Shreya Buch United States 8 114 0.5× 182 1.7× 37 0.5× 108 1.5× 30 0.5× 8 412
Filomena O. Dimayuga United States 10 165 0.7× 222 2.1× 27 0.3× 103 1.5× 56 0.9× 11 610
Shaona Acharjee Canada 14 160 0.7× 189 1.8× 54 0.7× 110 1.6× 39 0.6× 18 561
Elizabeth M. Podhaizer United States 9 100 0.4× 152 1.4× 35 0.4× 89 1.3× 32 0.5× 9 391
Ana Borrajo Spain 13 213 0.9× 206 2.0× 63 0.8× 182 2.6× 15 0.2× 21 701
Melissa Cosenza United States 7 94 0.4× 206 2.0× 75 0.9× 70 1.0× 31 0.5× 7 469
Virginia Protto Italy 13 179 0.8× 160 1.5× 32 0.4× 74 1.1× 55 0.9× 18 680
Yutaka Yamamuro Japan 12 140 0.6× 39 0.4× 25 0.3× 88 1.3× 31 0.5× 36 478

Countries citing papers authored by Tsuyoshi Ando

Since Specialization
Citations

This map shows the geographic impact of Tsuyoshi Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuyoshi Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuyoshi Ando more than expected).

Fields of papers citing papers by Tsuyoshi Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsuyoshi Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuyoshi Ando. The network helps show where Tsuyoshi Ando may publish in the future.

Co-authorship network of co-authors of Tsuyoshi Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Tsuyoshi Ando. A scholar is included among the top collaborators of Tsuyoshi Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuyoshi Ando. Tsuyoshi Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ando, Tsuyoshi, Takeshi Nabeshima, Shingo Inoue, et al.. (2021). Severe Fever with Thrombocytopenia Syndrome in Cats and Its Prevalence among Veterinarian Staff Members in Nagasaki, Japan. Viruses. 13(6). 1142–1142. 29 indexed citations
2.
Tun, Mya Myat Ngwe, Takeshi Nabeshima, Shyam Prakash Dumre, et al.. (2020). Unusual, neurological and severe dengue manifestations during the outbreak in Sri Lanka, 2017. Journal of Clinical Virology. 125. 104304–104304. 28 indexed citations
3.
Tun, Mya Myat Ngwe, Tsuyoshi Ando, Shyam Prakash Dumre, et al.. (2020). Clinical, Virological, and Cytokine Profiles of Children Infected with Dengue Virus during the Outbreak in Southern Vietnam in 2017. American Journal of Tropical Medicine and Hygiene. 102(6). 1217–1225. 9 indexed citations
4.
Tun, Mya Myat Ngwe, Takeshi Nabeshima, Corazon C. Buerano, et al.. (2019). Japanese Encephalitis- and Dengue-Associated Acute Encephalitis Syndrome Cases in Myanmar. American Journal of Tropical Medicine and Hygiene. 100(3). 643–646. 12 indexed citations
5.
Tun, Mya Myat Ngwe, Corazon C. Buerano, Takeshi Nabeshima, et al.. (2018). Isolation and genomic characterization of Culex flaviviruses from mosquitoes in Myanmar. Virus Research. 247. 120–124. 9 indexed citations
7.
Omi, Kazuya, Tsuyoshi Ando, Takashi Shirakawa, et al.. (2015). Noncompetitive Immunoassay Detection System for Haptens on the Basis of Antimetatype Antibodies. Clinical Chemistry. 61(4). 627–635. 28 indexed citations
8.
Shimizu, Kanako, Takuya Mizuno, Jun Shinga, et al.. (2012). Vaccination with Antigen-Transfected, NKT Cell Ligand–Loaded, Human Cells Elicits Robust In Situ Immune Responses by Dendritic Cells. Cancer Research. 73(1). 62–73. 32 indexed citations
9.
Ando, Tsuyoshi, et al.. (2004). Effects of nefiracetam on the levels of brain-derived neurotrophic factor and synapsin I mRNA and protein in the hippocampus of microsphere-embolized rats. European Journal of Pharmacology. 507(1-3). 49–56. 11 indexed citations
10.
Takeo, Satoshi, et al.. (2003). Persistent Effects of Delayed Treatment with Nefiracetam on the Water Maze Task in Rats with Sustained Cerebral Ischemia. Journal of Pharmacology and Experimental Therapeutics. 304(2). 513–523. 8 indexed citations
12.
Takeo, Satoshi, et al.. (2003). Effects of Nefiracetam on Cerebral Adenylyl Cyclase Activity in Rats with Microsphere Embolism-Induced Memory Dysfunction.. Biological and Pharmaceutical Bulletin. 26(3). 318–322. 1 indexed citations
13.
Okuyama, Noriko, et al.. (2002). Effects of nefiracetam on spatial memory function and acetylcholine and GABA metabolism in microsphere-embolized rats. European Journal of Pharmacology. 453(1). 59–67. 14 indexed citations
14.
Sato, Kazuo, Takeshi Fujii, Yoshihiro Watanabe, et al.. (1999). Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neuroscience Letters. 266(1). 17–20. 209 indexed citations
15.
Tanonaka, Kouichi, et al.. (1999). Role of an ATP-Sensitive Potassium Channel Opener, YM934, in Mitochondrial Energy Production in Ischemic/Reperfused Heart. Journal of Pharmacology and Experimental Therapeutics. 291(2). 710–716. 21 indexed citations
16.
Terai, Takao, Yasuhiro Kita, Tsuyoshi Ando, et al.. (1995). A novel non-xanthine adenosine A1 receptor antagonist. European Journal of Pharmacology. 279(2-3). 217–225. 22 indexed citations
17.
Terai, Takao, Yuichi Kita, Tsuyoshi Ando, et al.. (1990). The renal effects of FR-113453, a potent non-xanthine adenosine antagonist. European Journal of Pharmacology. 183(3). 1057–1058. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026